Skip to Main Content

Author Details

Lauren C Peres
H. Lee Moffit Cancer Center and Research Institute
2016
56
17
PMIDPaper TitleJournal TitlePublished Year
36520244Survival of epithelial ovarian cancer in Black women: a society to cell approach in the African American cancer epidemiology study (AACES).Cancer Causes Control2023
37558706Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.Blood Cancer J2023
37537254Association of inflammation-related exposures and ovarian cancer survival in a multi-site cohort study of Black women.Br J Cancer2023
37024666Impact of obesity on chemotherapy dosing of carboplatin and survival of women with ovarian cancer.Br J Cancer2023
37159277Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer.Obstet Gynecol2023
37307173Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.Blood Adv2023
37235841Reply to R. Chakraborty et al.J Clin Oncol2023
37137500Prevention of Epithelial Ovarian Cancer.Cold Spring Harb Perspect Med2023
36623248Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.J Clin Oncol2023
35235563Tumor immune cell clustering and its association with survival in African American women with ovarian cancer.PLoS Comput Biol2022
35654411Race Differences in the Associations between Menstrual Cycle Characteristics and Epithelial Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2022
35500227Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma.Blood Adv2022
35633315Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium.Int J Cancer2022
35487774The impact of distance to closest negative margin on survival after pelvic exenteration.Gynecol Oncol2022
35939783Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma.Blood Adv2022
36138071Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium.Br J Cancer2022
35219512The knowns and unknowns of disparities, biology, and clinical outcomes in Hispanic and Latinx multiple myeloma patients in the U.S.Semin Oncol2022
34882782Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study.Cancer2022
35244678Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma.Cancer Epidemiol Biomarkers Prev2022
34204319Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data.Cancers (Basel)2021
33719520A transdisciplinary approach to understand the epigenetic basis of race/ethnicity health disparities.Epigenomics2021
33521947First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women.Int J Cancer2021
33563649Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies.Cancer Epidemiol Biomarkers Prev2021
34734969spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data.Bioinformatics2021
34475121Scratching Below the Ovarian Cancer GWAS Surface.Cancer Epidemiol Biomarkers Prev2021
34155063Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium.Cancer Epidemiol Biomarkers Prev2021
31469419Identification of novel epithelial ovarian cancer loci in women of African ancestry.Int J Cancer2020
31839342Predictors of survival trajectories among women with epithelial ovarian cancer.Gynecol Oncol2020
31851060Expression of the Immune Checkpoints LAG-3 and PD-L1 in High-grade Serous Ovarian Carcinoma: Relationship to Tumor-associated Lymphocytes and Germline BRCA Status.Int J Gynecol Pathol2020
32362566Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES).Gynecol Oncol2020
32241384Racial/ethnic disparities in ovarian cancer research.Adv Cancer Res2020
29485423Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).Int J Gynecol Pathol2019
31415710Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study.Cancer2019
31236792Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.Cancer Causes Control2019
31152675Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma.J Nutr2019
31001917Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.Cancer Med2019
30481095Effect of Cultural, Folk, and Religious Beliefs and Practices on Delays in Diagnosis of Ovarian Cancer in African American Women.J Womens Health (Larchmt)2019
30307782Individual, Social, and Societal Correlates of Health-Related Quality of Life Among African American Survivors of Ovarian Cancer: Results from the African American Cancer Epidemiology Study.J Womens Health (Larchmt)2019
29718305Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.J Natl Cancer Inst2019
29211900Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.Int J Epidemiol2018
29961757Reply to 'Comment on 'Dairy, calcium, vitamin D and ovarian cancer risk in African-American women''.Br J Cancer2018
30121132Histotype classification of ovarian carcinoma: A comparison of approaches.Gynecol Oncol2018
29584862Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.Int J Epidemiol2018
29188593Recreational physical activity and survival in African-American women with ovarian cancer.Cancer Causes Control2018
27727481Dietary inflammatory index and risk of epithelial ovarian cancer in African American women.Int J Cancer2017
28251458Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.Cancer Causes Control2017
28444120Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.Am J Epidemiol2017
28466107Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES).Cancer Causes Control2017
29226065Challenges and Opportunities in Studying the Epidemiology of Ovarian Cancer Subtypes.Curr Epidemiol Rep2017
28698324The Women and Their Children's Health (WaTCH) study: methods and design of a prospective cohort study in Louisiana to examine the health effects from the BP oil spill.BMJ Open2017
  • 1 - 50 of 56

Recommended Authors

University of British Columbia, and Vancouver General Hospital
Career Start Year 2016
Number of shared co-authors 39
Institute of Clinical Trials and Methodology, University College London
Career Start Year 2015
Number of shared co-authors 41
Alberta Health Services-Cancer Care
Career Start Year 2014
Number of shared co-authors 41
University of Cambridge
Career Start Year 2013
Number of shared co-authors 41
Oregon Health & Science University
Career Start Year 2013
Number of shared co-authors 39
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 2012
Number of shared co-authors 48
Weill Cornell Medical College
Career Start Year 2009
Number of shared co-authors 0
Uniformed Services of the Health Sciences Gynecologic Cancer Center of Excellence
Career Start Year 2007
Number of shared co-authors 28
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2006
Number of shared co-authors 48
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 15
Fox Chase Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Moffitt Cancer Center
Career Start Year 2004
Number of shared co-authors 42
University Hospital
Career Start Year 2002
Number of shared co-authors 39
National Cancer Institute, National Institute of Health, 9 Medical Center Drive
Career Start Year 2002
Number of shared co-authors 48
Peter MacCallum Cancer Centre
Career Start Year 2002
Number of shared co-authors 41
Peter MacCallum Cancer Centre
Career Start Year 2001
Number of shared co-authors 43
QIMR Berghofer Medical Research Institute
Career Start Year 2000
Number of shared co-authors 47
University of British Columbia
Career Start Year 2000
Number of shared co-authors 13
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 1
Beckman Research Institute of City of Hope
Career Start Year 1997
Number of shared co-authors 22
Weill Cornell Medical College
Career Start Year 1996
Number of shared co-authors 1
Roswell Park Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 30
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 30
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Career Start Year 1991
Number of shared co-authors 35
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 8
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 27
Mayo Clinic
Career Start Year 1987
Number of shared co-authors 46
German Cancer Research Center (DKFZ)
Career Start Year 1985
Number of shared co-authors 49
German Cancer Research Center (DKFZ)
Career Start Year 1984
Number of shared co-authors 51

Collaborators

Rollins School of Public Health, Emory University
Co-authored papers 37
Co-authored papers 31
Co-authored papers 29
National Cancer Institute
Co-authored papers 20
University of Southern California
Co-authored papers 11
Co-authored papers 9
Huntsman Cancer Institute, University of Utah
Co-authored papers 8
Vanderbilt University Medical Center
Co-authored papers 8
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 8
Duke School of Medicine
Co-authored papers 7
Fred Hutchinson Cancer Research Center
Co-authored papers 5
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 5
Co-authored papers 4
University of Michigan School of Public Health ann arbor
Co-authored papers 4
Co-authored papers 4
Memorial Sloan-Kettering Cancer Center
Co-authored papers 4
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
Co-authored papers 3
University of California irvine
Co-authored papers 3
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 3
University of Southern California
Co-authored papers 2
University of Calgary
Co-authored papers 2
Cedars-Sinai Medical Center
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Keck School of Medicine, University of Southern California
Co-authored papers 2